• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content

General Psychiatry

Unbiased coverage of all things psychiatric
Home » Topics » General Psychiatry
  • November 18, 2025

    Topiramate (Eprontia, Qudexy XR, Topamax, Trokendi XR) Fact Sheet [G] for General Psychiatry

    Topiramate is a reasonable off-label choice for alcohol use disorder and antipsychotic-induced weight gain.

  • November 18, 2025
    By Talia Puzantian, PharmD, BCPP

    Pregabalin (Lyrica, Lyrica CR) Fact Sheet [G] for General Psychiatry

    Pregabalin is structurally related to gabapentin and is likely more effective for psychiatric disorders, especially generalized anxiety disorder (GAD) and social anxiety disorder. 

  • November 18, 2025
    By Talia Puzantian, PharmD, BCPP

    Atomoxetine (Strattera) Fact Sheet [G] for General Psychiatry

    Atomoxetine is a nonstimulant attention-deficit/hyperactivity disorder (ADHD) treatment that carries no abuse potential, causes less insomnia and anxiety, and is unlikely to worsen tics.


Read More
  • November 18, 2025
    By Talia Puzantian, PharmD, BCPP

    Valproic Acid (Depakene, Depakote, others) Fact Sheet [G]

  • November 18, 2025
    By Talia Puzantian, PharmD, BCPP

    Oxcarbazepine (Oxtellar XR, Trileptal) Fact Sheet [G] for General Psychiatry

  • November 18, 2025
    By Talia Puzantian, PharmD, BCPP

    Clonidine (Catapres, Kapvay) Fact Sheet [G] for General Psychiatry

  • November 18, 2025
    By Talia Puzantian, PharmD, BCPP

    Amphetamine (Adzenys XR-ODT, Dyanavel XR, Evekeo) Fact Sheet [G] for General Psychiatry

  • Dttd phone
    November 7, 2025
    By Chris Aiken, MD

    Difficult To Treat Depression: A Carlat Guide - PDF/eBook

  • November 7, 2025
    By Chris Aiken, MD

    Difficult To Treat Depression: A Carlat Guide

  • November 3, 2025
    By Daniel Carlat, MD

    Omega-3 Fatty Acids (Fish Oil) Fact Sheet for General Psychiatry

  • November 3, 2025
    By Daniel Carlat, MD

    Lithium (Eskalith, Lithobid) Fact Sheet for General Psychiatry

  • November 3, 2025
    By Daniel Carlat, MD

    Lamotrigine (Lamictal, Lamictal XR, Subvenite) Fact Sheet

  • November 3, 2025
    By Daniel Carlat, MD

    Carbamazepine (Epitol, Equetro, Tegretol, others) Fact Sheet

Read More

Blog Posts

  • November 17, 2025
    By Daniel Carlat, MD

    Deprescribing Antipsychotics: Why Stopping Can Be Harder Than Starting (Med Fact Book Mini-Series)

  • 1760619129523
    November 12, 2025
    By Daniel Carlat, MD

    Switching Antipsychotics (Med Fact Book Mini-Series, Part 3)

  • Shutterstock 2700377353
    November 10, 2025
    By Chris Aiken, MD

    TMS, Teens, and Antidepressants

  • November 4, 2025
    By Daniel Carlat, MD

    Switching Antidepressants: Direct Switch vs. Cross Taper (Med Fact Book Mini-Series, Part 2)

  • Shutterstock 2697712297
    November 3, 2025
    By Chris Aiken, MD

    How to Explain TMS

Read More

Products

  • 3dcover dttd1e sm3

    Difficult To Treat Depression: A Carlat Guide (2026)

    $99.95$99.95
  • Dttd phone2

    Difficult To Treat Depression: A Carlat Guide (2026) - PDF/eBook

    $79.95$79.95
  • Pb5e ebook cover

    Psychiatry Practice Boosters, Fifth Edition (2026) - PDF/eBook

    $49.95
  • Pb5e 3dcover

    Psychiatry Practice Boosters, Fifth Edition (2026)

    $74.95
More Products

Authors

  • Erick Turner, MD
  • Avneet Soin, MD.
  • Sahil Munjal, MD
  • M. Katherine Shear, MD
  • Louis Cozolino, PhD
  • Carl Salzman MD
More Authors

Videos

  • Karxt (cobenfy)  the breakthrough antipsychotic that could change everything
    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
  • Alpha2thumb
    Alpha-2 Agonists Review: Clonidine (Kapvay) and Guanfacine (Intuniv), Non-Stimulant ADHD Medications
  • What you need to know about gepirone (exxua)   benefits side effects and review of trials thumb
    What You Need to Know About Gepirone (Exxua) | Benefits, Side Effects, and Review of Trials
  • Stimulant dosing thumb
    Stimulant-Dosing-Limits-for-ADHD-When-Is-The-Adderall--Ritalin-Dose-Too-High.mp4
  • Cpn4 thumb
    Carlat-Psychiatry-News-_-Stimulant-Fraud--Oral-Ketamine--E-Cigarettes--Benzo-Tapering--CBD.mp4
  • Methylphenidate thumb
    L-Methylfolate-May-Offer-Modest-Boost-to-Antidepressants.mp4
More Videos

Audio

    More Audio

    Pages

    • The Carlat Psychiatry Report (TCPR) Editorial Information

    Downloads

    • How to Administer the Bush Francis Catatonia Rating Scalegen
    • Motivational Interviewing on the Inpatient Psych Unitgen
    • Complete Blood Countgen
    More
    Carlat Total Access Subscriptions: Get access to every article on the website.

    Complete access to every article you search on the website.

    Shop for Total Access
    Free Psychiatry Updates
    The latest unbiased psychiatric information sent to your inbox.
    Specify Your Interests
    Featured Book
    • 3DCover_DTTD1e_sm3.png

      Difficult To Treat Depression: A Carlat Guide (2026)

      Effective tools for your most challenging cases.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2700377353.jpg
      General Psychiatry

      TMS, Teens, and Antidepressants

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.